Yahoo! News - Latest News & Headlines |
- Japan's Biggest Bank CEO Joins Exodus From Saudi Business Forum
- Khaled El Mays's Beirut Abode Blurs The Line Between Home and Showroom
- Novartis drug cut death risk by 35 percent in gene mutation breast cancer
- Long queues as Afghan voters defy election day attacks, delays
- The Latest: 2 suspects charged in Georgia officer's slaying
- New treatment offers up to ten months extra life for women with deadly breast cancer
- Trump Makes No Mention Of Khashoggi Murder During Arizona Rally
- U.S. Mega Millions lottery hits record $1.6 billion after no winners on Friday
- Saudis Used Mole At Twitter To Track Dissidents For Troll Farm: Report
- Rep. Steve King Goes Full White Nationalist In Interview With Austrian Site
Japan's Biggest Bank CEO Joins Exodus From Saudi Business Forum Posted: 21 Oct 2018 12:39 PM PDT MUFG Bank Ltd. CEO Kanetsugu Mike won't attend the Future Investment Initiative conference that begins Tuesday, spokesman Kazunobu Takahara said Sunday by phone, without giving a reason for his withdrawal. Eiichi Yoshikawa, deputy president of the unit of Mitsubishi UFJ Financial Group Inc., will go instead, Takahara said. This posting includes an audio/video/photo media file: Download Now |
Khaled El Mays's Beirut Abode Blurs The Line Between Home and Showroom Posted: 21 Oct 2018 11:33 AM PDT |
Novartis drug cut death risk by 35 percent in gene mutation breast cancer Posted: 21 Oct 2018 08:09 AM PDT The Swiss drugmaker's BYL719, a so-called PI3K inhibitor also known as alpelisib, combined with hormone therapy fulvestrant boosted median progression-free survival (PFS) to 11 months, up from 5.7 months for patients who got only hormone therapy, the company said on Saturday. BYL719 plus fulvestrant cut risk of death or progression in those patients by an estimated 35 percent, Novartis said. Novartis said earlier this year that this study, called SOLAR-1, of hormone receptor positive, HER2- breast cancer with mutations of the PIK3CA gene showed that YL719 helped patients. This posting includes an audio/video/photo media file: Download Now |
Long queues as Afghan voters defy election day attacks, delays Posted: 21 Oct 2018 05:33 AM PDT A suicide bomber killed 15 people in Kabul, the most serious of a series of smaller-scale attacks that caused dozens of casualties across the country but did not deter voters who endured long queues to cast their ballot. "Today the people gave an unanswerable response to the enemies of Afghanistan," government spokesman Haroon Chakansuri told reporters. Voting should have been over by the time the suicide bomber struck a polling station in the north of Kabul, killing 10 civilians and five police, but polling stations were kept open longer than normal to cope with large numbers of people who had been unable to cast ballots. This posting includes an audio/video/photo media file: Download Now |
The Latest: 2 suspects charged in Georgia officer's slaying Posted: 21 Oct 2018 01:03 AM PDT SNELLVILLE, Ga. (AP) — The Latest on the fatal shooting of a Georgia police officer (all times local): This posting includes an audio/video/photo media file: Download Now |
New treatment offers up to ten months extra life for women with deadly breast cancer Posted: 20 Oct 2018 10:11 PM PDT A new treatment could offer up to ten months extra life for women with one of the most aggressive forms of breast cancer, following a successful British trial. Using a combination of immunotherapy and chemotherapy, the body's own immune system can be tuned to attack triple-negative breast cancer, scientists found. The research, carried out by Queen Mary University of London (QMUL) and St Bartholomew's Hospital, also showed that the combined treatment reduced the risk of death or the cancer progressing by up to 40 per cent. Professor Peter Schmid, a professor of cancer medicine at QMUL and the author of the trial, described the results as a "massive step forward". "Triple-negative breast cancer is an aggressive form of breast cancer; we have been desperately looking for better treatment options," he said. "It is particularly tragic that those affected are often young, with many themselves having young families." Triple-negative breast cancer is one of the most deadly forms of the disease and nearly one quarter of patients diagnosed will not survive for more than five years. The standard treatment for it is chemotherapy, which most patients quickly develop resistance to. If the disease spreads to other parts of the body, survival is typically only 12 to 15 months. But with the new treatment, researchers say that survival could be extended by up to ten months. Prof Schmid, who is clinical director of the Breast Cancer Centre at St Bartholomew's Hospital, explained that he new treatment will "significantly extend lives compared to the standard treatment of chemotherapy alone." "We are changing how triple-negative breast cancer is treated in proving for the first time that immune therapy has a substantial survival benefit," he said. "In a combined treatment approach, we are using chemotherapy to tear away the tumour's 'immune-protective cloak' to expose it as well as enabling people's own immune system to get at it." About | Breast cancer The new treatment combines the standard weekly chemotherapy with the immunotherapy medication atezolizumab which once every two weeks. The combination works by chemotherapy "roughening up" the surface of the cancer, which enables the immune system to better recognise and therefore fight the cancer as a foreign object. Following the results of this trial, which were published in the New England Journal of Medicine, the new treatment is now under review by health authorities who will decide whether to offer it on the NHS. Patients at St Bartholomew's Hospital with triple-negative breast cancer are offered immunotherapy as part of ongoing trials. Triple negative breast cancer is more common in women under 40 and black women, according to Macmillan Cancer Support. It is one of the rarer forms of breast cancer, with around 15 per cent of breast cancers classified as triple negative. This posting includes an audio/video/photo media file: Download Now |
Trump Makes No Mention Of Khashoggi Murder During Arizona Rally Posted: 20 Oct 2018 09:21 PM PDT President Donald Trump discussed many of his usual talking points ― his prized This posting includes an audio/video/photo media file: Download Now |
U.S. Mega Millions lottery hits record $1.6 billion after no winners on Friday Posted: 20 Oct 2018 06:58 PM PDT The next Mega Millions draw will be on Tuesday, after no one hit all of the numbers of 15, 23, 53, 65, 70 and the Mega Ball 7 during Friday night's draw. "Mega Millions has already entered historic territory, but it's truly astounding to think that now the jackpot has reached an all-time world record," Gordon Medenica, lead director of the Mega Millions Group, said in a statement. The current jackpot beats the previous record, a $1.586 billion jackpot for a Powerball drawing in 2016, said Seth Elkin, a spokesman for Mega Millions. This posting includes an audio/video/photo media file: Download Now |
Saudis Used Mole At Twitter To Track Dissidents For Troll Farm: Report Posted: 20 Oct 2018 06:19 PM PDT The Saudi government apparently groomed a mole inside Twitter to keep tabs on This posting includes an audio/video/photo media file: Download Now |
Rep. Steve King Goes Full White Nationalist In Interview With Austrian Site Posted: 20 Oct 2018 02:32 PM PDT Rep. Steve King (R-Iowa) visited Austria in August and gave an extensive This posting includes an audio/video/photo media file: Download Now |
You are subscribed to email updates from Yahoo! News - Latest News & Headlines. To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
Google, 1600 Amphitheatre Parkway, Mountain View, CA 94043, United States |
Aucun commentaire:
Enregistrer un commentaire